Nano-X Imaging (NNOX) director Alroy details initial share and option stakes

Rhea-AI Filing Summary

Nano-X Imaging Ltd. director Erez Alroy filed an initial ownership report showing direct holdings of the company’s ordinary shares and stock options. He reports 6,962 ordinary shares in one line and 17,544 ordinary shares in another, reflecting different grant types.

Alroy also holds stock options covering 50,000 ordinary shares with a fixed exercise price of $17.63 per share that expire on December 28, 2032, and options over 10,000 ordinary shares at $11.52 per share expiring on December 31, 2033. Footnotes explain that one ordinary-share position consists of restricted share units granted on December 10, 2025, vesting in twelve equal monthly installments over one year, and that the option grants vest in 16 equal quarterly installments over four years from their respective reference dates.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Alroy Erez

Role Director

Type	Security	Shares	Price	Value
holding	Stock Option (right to buy ordinary shares)	--	--	--
holding	Stock Option (right to buy ordinary shares)	--	--	--
holding	Ordinary shares	--	--	--
holding	Ordinary shares	--	--	--

Holdings After Transaction: Stock Option (right to buy ordinary shares) — 50,000 shares (Direct); Ordinary shares — 6,962 shares (Direct)

Footnotes (1)

1. The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date. The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the date of appointment of the Reporting Person to the Issuer's Board of Directors on June 30, 2022, such that all options reported in this row will be exercisable on the four-year anniversary of that appointment date (June 30, 2026). The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027).

Key Figures

Ordinary shares holding 1: 6,962 shares Ordinary shares holding 2: 17,544 shares Stock options grant 2022: 50,000 shares at $17.63 +4 more

7 metrics

Ordinary shares holding 1 6,962 shares Direct ordinary shares reported as of the Form 3 date

Ordinary shares holding 2 17,544 shares Additional direct ordinary shares reported as of the Form 3 date

Stock options grant 2022 50,000 shares at $17.63 Options over ordinary shares, expiration December 28, 2032

Stock options grant 2023 10,000 shares at $11.52 Options over ordinary shares, expiration December 31, 2033

RSU vesting period 12 monthly installments Restricted share units granted December 10, 2025 vest over one year

Option vesting 2022 grant 16 installments of 6.25% Quarterly vesting from June 30, 2022 to June 30, 2026

Option vesting 2023 grant 16 installments of 6.25% Three-month anniversaries from August 14, 2023 to August 14, 2027

Key Terms

restricted share units, Stock Option (right to buy ordinary shares), ordinary shares, vest and become exercisable, +1 more

5 terms

restricted share units financial

"consist of shares underlying restricted share units that were granted to the Reporting Person"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

Stock Option (right to buy ordinary shares) financial

"security_title: Stock Option (right to buy ordinary shares)"

ordinary shares financial

"The ordinary shares reported in this row consist of shares underlying restricted share units"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

vest and become exercisable financial

"vest and become exercisable in 16 equal quarterly installments of 6.25% each"

grant approval date financial

"four-year anniversary of that grant approval date (August 14, 2027)"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Alroy Erez

(Last) (First) (Middle)

C/O NANO-X IMAGING LTD., OFER TECH PARK

94 SHLOMO SHMELTZER ROAD

(Street)

PETACH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	6,962	D
Ordinary shares(1)	17,544	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)	(2)	12/28/2032	Ordinary shares	50,000	$17.63	D
Stock Option (right to buy ordinary shares)	(3)	12/31/2033	Ordinary shares	10,000	$11.52	D

Explanation of Responses:

1. The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date.

2. The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the date of appointment of the Reporting Person to the Issuer's Board of Directors on June 30, 2022, such that all options reported in this row will be exercisable on the four-year anniversary of that appointment date (June 30, 2026).

3. The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027).

Remarks:

Exhibit 24.1 Power of Attorney

	/s/ Marina Gofman Feler, attorney-in-fact	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Nano-X Imaging (NNOX) director Erez Alroy report on this Form 3?

He reports his initial ownership of Nano-X Imaging ordinary shares and stock options as a company director. The filing lists two direct ordinary-share positions and two option grants over additional ordinary shares, along with detailed vesting schedules and option expiration dates.

How many Nano-X Imaging ordinary shares does Erez Alroy directly hold on this Form 3?

The filing shows two direct positions in ordinary shares: one of 6,962 shares and another of 17,544 shares. One of these positions consists of shares underlying restricted share units that vest monthly over one year from a December 10, 2025 grant date.

What stock options over Nano-X Imaging (NNOX) shares does Erez Alroy report?

He reports stock options over 50,000 ordinary shares with a $17.63 exercise price expiring December 28, 2032, and options over 10,000 ordinary shares with an $11.52 exercise price expiring December 31, 2033. Both grants vest in 16 equal installments of 6.25% each.

How do Erez Alroy’s restricted share units in Nano-X Imaging vest?

Restricted share units granted on December 10, 2025 vest in twelve equal monthly installments. This schedule means the underlying ordinary shares will be fully vested on the one-year anniversary of the grant date, creating a steady monthly release of vested shares over that period.

What is the vesting schedule for Erez Alroy’s 2022 Nano-X Imaging option grant?

Options granted December 28, 2022 vest in 16 equal quarterly installments of 6.25% each, starting from June 30, 2022, his Board appointment date. All options from this grant become fully exercisable on the four-year anniversary of that appointment, June 30, 2026.

What is the vesting schedule for Erez Alroy’s 2023 Nano-X Imaging option grant?

Options granted December 31, 2023 vest in 16 equal installments of 6.25% each on every three-month anniversary of August 14, 2023, the Board approval date. All options from this grant become exercisable on the four-year anniversary of that approval date, August 14, 2027.